Status:
COMPLETED
Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Geisinger Clinic
Duke University
Conditions:
Chronic Kidney Disease
Chronic Kidney Disease Requiring Chronic Dialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
More than 80% of individuals in the U.S. start maintenance hemodialysis (HD) with a central venous catheter, despite substantial evidence that starting HD with an arteriovenous (AV) access improves qu...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients:
- Receive care at the Geisinger Danville Nephrology Clinic
- Age ≥ 18 years
- eGFR ≤ 25 mL/min/1.73 m and 2-year kidney failure risk score \>10% based on kidney failure risk equation, or nephrologist recommendation for vascular access
- Participation in the Vascular Access Navigation and Education Quality Improvement Program
- Providers: Professional involved in dialysis vascular access care (e.g., nephrologist, surgeon, kidney disease clinic nurse, etc.) at Geisinger in Danville, PA
- Exclusion Criteria
- Patients:
- Too far into the vascular access creation process to benefit from the intervention (e.g. completed vascular access surgery appointment or has a surgery appointment scheduled within the next 4 weeks),
- Inability to consent, or
- Inability to complete interviews in English
- Providers: None
Exclusion
Key Trial Info
Start Date :
July 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2020
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04032613
Start Date
July 30 2019
End Date
June 22 2020
Last Update
January 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Danville Nephrology Clinic
Danville, Pennsylvania, United States, 17822